Jonathan Jagid, MD

Why follow Jonathan

Jonathan Jagid is PRIME2 principal investigator at University of Miami at University of Miami. ClinicalTrials.gov first posted PRIME2 (NCT07929792) on November 10, 2026. The early feasibility study evaluates the N1 implant and R1 robot in up to 10 adults with spinal cord injury, ALS or chronic ischemic stroke, at up to five U.S. sites. The first listed site is the University of Miami, with principal investigator Jonathan Jagid, MD. The primary endpoint records serious adverse device effects from implantation through the 90-day follow-up visit. Estimated enrollment and planned sites are not completed outcomes; this is an investigational device study.